Albert David Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 26, 2025, 4:25 pm

Competitors of Albert David Ltd

All Competitor Stocks of Albert David Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:05 pm

Below is a detailed analysis of the quarterly data for Albert David Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 70.57 Cr.. The value appears to be declining and may need further review. It has decreased from 74.89 Cr. (Mar 2025) to 70.57 Cr., marking a decrease of 4.32 Cr..
• For Expenses, as of Jun 2025, the value is 81.23 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 79.64 Cr. (Mar 2025) to 81.23 Cr., marking an increase of 1.59 Cr..
• For Operating Profit, as of Jun 2025, the value is -10.66 Cr.. The value appears to be declining and may need further review. It has decreased from -4.75 Cr. (Mar 2025) to -10.66 Cr., marking a decrease of 5.91 Cr..
• For OPM %, as of Jun 2025, the value is -15.11%. The value appears to be declining and may need further review. It has decreased from -6.34% (Mar 2025) to -15.11%, marking a decrease of 8.77%.
• For Other Income, as of Jun 2025, the value is 22.04 Cr.. The value appears strong and on an upward trend. It has increased from -5.11 Cr. (Mar 2025) to 22.04 Cr., marking an increase of 27.15 Cr..
• For Interest, as of Jun 2025, the value is 0.55 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.13 Cr. (Mar 2025) to 0.55 Cr., marking an increase of 0.42 Cr..
• For Depreciation, as of Jun 2025, the value is 2.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.82 Cr. (Mar 2025) to 2.39 Cr., marking an increase of 0.57 Cr..
• For Profit before tax, as of Jun 2025, the value is 8.44 Cr.. The value appears strong and on an upward trend. It has increased from -11.81 Cr. (Mar 2025) to 8.44 Cr., marking an increase of 20.25 Cr..
• For Tax %, as of Jun 2025, the value is 5.92%. The value appears to be increasing, which may not be favorable. It has increased from -12.53% (Mar 2025) to 5.92%, marking an increase of 18.45%.
• For Net Profit, as of Jun 2025, the value is 7.94 Cr.. The value appears strong and on an upward trend. It has increased from -10.33 Cr. (Mar 2025) to 7.94 Cr., marking an increase of 18.27 Cr..
• For EPS in Rs, as of Jun 2025, the value is 13.91. The value appears strong and on an upward trend. It has increased from -18.10 (Mar 2025) to 13.91, marking an increase of 32.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:48 am

Growth

Last Updated: September 4, 2025, 10:40 pm

Balance Sheet

Last Updated: June 16, 2025, 12:31 pm

Below is a detailed analysis of the balance sheet data for Albert David Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
• For Reserves, as of Mar 2025, the value is 387.00 Cr.. The value appears strong and on an upward trend. It has increased from 377.00 Cr. (Mar 2024) to 387.00 Cr., marking an increase of 10.00 Cr..
• For Borrowings, as of Mar 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 9.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 107.00 Cr.. The value appears to be improving (decreasing). It has decreased from 112.00 Cr. (Mar 2024) to 107.00 Cr., marking a decrease of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 511.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 498.00 Cr. (Mar 2024) to 511.00 Cr., marking an increase of 13.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Mar 2024) to 99.00 Cr., marking an increase of 16.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 5.00 Cr..
• For Investments, as of Mar 2025, the value is 260.00 Cr.. The value appears to be declining and may need further review. It has decreased from 273.00 Cr. (Mar 2024) to 260.00 Cr., marking a decrease of 13.00 Cr..
• For Other Assets, as of Mar 2025, the value is 151.00 Cr.. The value appears strong and on an upward trend. It has increased from 135.00 Cr. (Mar 2024) to 151.00 Cr., marking an increase of 16.00 Cr..
• For Total Assets, as of Mar 2025, the value is 511.00 Cr.. The value appears strong and on an upward trend. It has increased from 498.00 Cr. (Mar 2024) to 511.00 Cr., marking an increase of 13.00 Cr..

Notably, the Reserves (387.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Albert David Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 30.14. This value is within the healthy range. It has decreased from 132.15 (Mar 24) to 30.14, marking a decrease of 102.01.
• For Diluted EPS (Rs.), as of Mar 25, the value is 30.14. This value is within the healthy range. It has decreased from 132.15 (Mar 24) to 30.14, marking a decrease of 102.01.
• For Cash EPS (Rs.), as of Mar 25, the value is 42.35. This value is within the healthy range. It has decreased from 144.11 (Mar 24) to 42.35, marking a decrease of 101.76.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 687.70. It has increased from 671.05 (Mar 24) to 687.70, marking an increase of 16.65.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 687.70. It has increased from 671.05 (Mar 24) to 687.70, marking an increase of 16.65.
• For Dividend / Share (Rs.), as of Mar 25, the value is 5.00. This value exceeds the healthy maximum of 3. It has decreased from 11.50 (Mar 24) to 5.00, marking a decrease of 6.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 605.85. It has decreased from 635.10 (Mar 24) to 605.85, marking a decrease of 29.25.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 57.13. This value is within the healthy range. It has decreased from 182.98 (Mar 24) to 57.13, marking a decrease of 125.85.
• For PBIT / Share (Rs.), as of Mar 25, the value is 44.92. This value is within the healthy range. It has decreased from 171.02 (Mar 24) to 44.92, marking a decrease of 126.10.
• For PBT / Share (Rs.), as of Mar 25, the value is 44.20. This value is within the healthy range. It has decreased from 170.46 (Mar 24) to 44.20, marking a decrease of 126.26.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 30.14. This value is within the healthy range. It has decreased from 132.15 (Mar 24) to 30.14, marking a decrease of 102.01.
• For PBDIT Margin (%), as of Mar 25, the value is 9.43. This value is below the healthy minimum of 10. It has decreased from 28.81 (Mar 24) to 9.43, marking a decrease of 19.38.
• For PBIT Margin (%), as of Mar 25, the value is 7.41. This value is below the healthy minimum of 10. It has decreased from 26.92 (Mar 24) to 7.41, marking a decrease of 19.51.
• For PBT Margin (%), as of Mar 25, the value is 7.29. This value is below the healthy minimum of 10. It has decreased from 26.84 (Mar 24) to 7.29, marking a decrease of 19.55.
• For Net Profit Margin (%), as of Mar 25, the value is 4.97. This value is below the healthy minimum of 5. It has decreased from 20.80 (Mar 24) to 4.97, marking a decrease of 15.83.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.38. This value is below the healthy minimum of 15. It has decreased from 19.69 (Mar 24) to 4.38, marking a decrease of 15.31.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.29. This value is below the healthy minimum of 10. It has decreased from 24.46 (Mar 24) to 6.29, marking a decrease of 18.17.
• For Return On Assets (%), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has decreased from 15.14 (Mar 24) to 3.36, marking a decrease of 11.78.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.68. It has decreased from 0.78 (Mar 24) to 0.68, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 3.40. This value exceeds the healthy maximum of 3. It has decreased from 3.75 (Mar 24) to 3.40, marking a decrease of 0.35.
• For Quick Ratio (X), as of Mar 25, the value is 2.79. This value exceeds the healthy maximum of 2. It has decreased from 3.31 (Mar 24) to 2.79, marking a decrease of 0.52.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.30. This value is below the healthy minimum of 4. It has decreased from 1.36 (Mar 24) to 1.30, marking a decrease of 0.06.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 38.15. This value is within the healthy range. It has increased from 6.81 (Mar 24) to 38.15, marking an increase of 31.34.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 27.15. This value is within the healthy range. It has increased from 6.24 (Mar 24) to 27.15, marking an increase of 20.91.
• For Earning Retention Ratio (%), as of Mar 25, the value is 61.85. This value is within the healthy range. It has decreased from 93.19 (Mar 24) to 61.85, marking a decrease of 31.34.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 72.85. This value exceeds the healthy maximum of 70. It has decreased from 93.76 (Mar 24) to 72.85, marking a decrease of 20.91.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 79.45. This value is within the healthy range. It has decreased from 325.13 (Mar 24) to 79.45, marking a decrease of 245.68.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 42.91. This value is within the healthy range. It has decreased from 235.81 (Mar 24) to 42.91, marking a decrease of 192.90.
• For Enterprise Value (Cr.), as of Mar 25, the value is 471.38. It has decreased from 584.89 (Mar 24) to 471.38, marking a decrease of 113.51.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has decreased from 1.61 (Mar 24) to 1.36, marking a decrease of 0.25.
• For EV / EBITDA (X), as of Mar 25, the value is 14.46. This value is within the healthy range. It has increased from 5.60 (Mar 24) to 14.46, marking an increase of 8.86.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has decreased from 1.69 (Mar 24) to 1.34, marking a decrease of 0.35.
• For Retention Ratios (%), as of Mar 25, the value is 61.84. This value is within the healthy range. It has decreased from 93.18 (Mar 24) to 61.84, marking a decrease of 31.34.
• For Price / BV (X), as of Mar 25, the value is 1.18. This value is within the healthy range. It has decreased from 1.60 (Mar 24) to 1.18, marking a decrease of 0.42.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has decreased from 1.69 (Mar 24) to 1.34, marking a decrease of 0.35.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 24) to 0.03, marking a decrease of 0.09.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness